EGFR and carcinoma: Many supporting studies are worth mentioning in this sense, for instance, those by Tolmachev et al. who showed rapid biodistribution and localized accumulation of affibodies in xenografted mice for imaging of EGFR-expressing tissues [83] or by Da Pieve et al. who produced a radio-labeled affibody able to specifically reach, bind, and image HER3, representing a challenging target marker modestly expressed by carcinoma cells [84].